ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2018 American Transplant Congress

    Time and Perfusate Dependent Molecular Response in Ex Vivo Lung Perfusion

    P. Dromparis,1 N. Aboelnazar,2 S. Wagner,1 S. Himmat,2 C. White,2 J. Luc,2 D. Freed,2 J. Nagendran,2 M. Mengel,1 B. Adam.1

    1Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada; 2Department of Surgery (Cardiac), University of Alberta, Edmonton, Canada.

    Lung transplantation has limited organ utilization and high rates of primary graft dysfunction, in part due to acute lung injury (ALI). Cold static preservation (CSP)…
  • 2018 American Transplant Congress

    The Aggressive Phenotype: Center-Level Characteristics in the Use of Suboptimal Lungs

    M. Kosztowski, E. Bush, X. Luo, A. Thomas, M. Bowring, D. Segev, J. Garonzik Wang.

    Johns Hopkins, Baltimore, MD.

    The disparity between organ supply and demand has led some centers to expand their criteria for donor selection. We explored utilization of suboptimal lungs to…
  • 2018 American Transplant Congress

    Risk Factors for Postoperative Bleeding after Lung Transplantation

    D. Adelmann,1,2 S. Koch,1 J. Menger,1 P. Jaksch,3 M. Kurz,1 M. Mouhieddine,1 W. Klepetko,3 B. Steinlechner.1

    1Department of Anesthesia, General Intensive Care and Pain Control, Medical University of Vienna, Vienna, Austria; 2Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA; 3Medical University of Vienna, Vienna, Austria.

    Bleeding complications after lung transplantation (LuTX) are associated with increased morbidity. Risk factors for postoperative bleeding complications after LuTX have not yet been reported. In…
  • 2017 American Transplant Congress

    Antibody Mapping by Protein Microarray Revealed a Unique Repertoire in Lung Transplant Recipients That Developed Chronic Lung Allograft Dysfunction.

    D. Nayak,1 K. Garcia,2 P. Pirrotte,2 R. Hachem,3 R. Bremner,1 M. Smith,1 T. Mohanakumar.1

    1Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ; 2Translational Genomics Research Institute, Phoenix, AZ; 3Washington University, St. Louis, MO

    Background: Development of chronic lung allograft dysfunction (CLAD) limits long-term success from lung transplantation (LTx). Elicitation of de novo antibody (Ab) to mismatched donor HLA…
  • 2017 American Transplant Congress

    Propensity-Score Matched Comparison of Lung Transplant Recipients of Age <70 and ≥70 Years.

    A. Kashem,1 S. Keshavamurthy,1 J. Gomez-Abraham,1 T. Yoshizumi,1 H. Zhao,2 F. Cordova,3 G. Criner,3 Y. Toyoda.1

    1Cardiovascular Surgery, Temple University, Philadelphia, PA; 2Clinical Sciences, Temple University, Philadelphia, PA; 3Thoracic and Pulmonary Medicine, Temple University, Philadelphia, PA

    Purpose: To validate the utilization of lung transplantation (LTx) recently in older recipients, we compared the survival outcome of the LTx recipients of age <70…
  • 2017 American Transplant Congress

    Autotransplantation of the Left Lung for the Treatment of Recurrent Life Threatening Pulmonary Hemorrhage Related to Pulmonary Vascular Malformation: A Unique Chance to Study Ischemia/Reperfusion Injury.

    C. Falk,1 I. Tudorache,2 C. Müller,3 W. Sommer,2 K. Daemen,1 J. Keil,1 G. Hansen,3 A. Haverich,2 G. Warnecke,2 N. Schwerk.3

    1Institute of Transplant Immunology, IFB-Tx, MHH, Hannover, Germany; 2Department of Cardiothoracic Transplant and Vascular Surgery, MHH, Hannover, Germany; 3Department of Pediatric Pneumology, MHH, Hannover, Deutschland, Germany

    Background: Ischemia reperfusion injury (IRI) remains a major clinical problem in lung transplantation. Here, we report the investigation of IRI in a 17-year-old patient who…
  • 2017 American Transplant Congress

    Addition of FEV1 Drop to LAS May Improve Access of CF Patients to Transplant: Analysis of the SRTR and US CF Foundation Patient Registries.

    E. Dasenbrook,1 M. Skeans,2 A. Fink,3 B. Marshall,3 M. Valapour.1,2

    1Cleveland Clinic, Cleveland; 2SRTR, Minneapolis; 3CF Foundation, Bethesda

    Lung transplant is a widely accepted treatment for cystic fibrosis (CF) end-stage lung disease. The US lung allocation score (LAS) system prioritizes transplant candidates primarily…
  • 2017 American Transplant Congress

    Lung Transplant Recipient Travel Distance to Transplant Center Does Not Impact Survival.

    W. Tsuang,1 S. Lin,2 J. Schold,2 M. Valapour.1

    1Respiratory Institute, Cleveland Clinic, Cleveland, OH; 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

    Purpose: We examined if the geographic distance recipients travel for lung transplant care impacts posttransplant survival at our center.Methods: Retrospective single center cohort study of…
  • 2017 American Transplant Congress

    Truth in Pathology: Autopsy Findings in Lungs Declined for Transplantation.

    A. Friedman, J. Lewis, H. Irving, K. Delli Carpini.

    LiveOnNY, New York, NY

    Healthy lungs are scarce among available organ donors who are becoming progressively older and have increasing numbers of comorbidities. Selection criteria that include excellent oxygenation…
  • 2017 American Transplant Congress

    Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.

    K. Freischlag,1 B. Ezekian,2 M. Mulvihill,2 S. Knechtle.2

    1School of Medicine, Duke University, Durham, NC; 2Surgery, Duke University, Durham, NC

    Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who would not be expected to survive transplantation of either organ alone. We present one of…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences